Table 1 Demographic data of the heart transplant patients.

From: CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients

Demographic data

CYP3A testing

CYP3A-status – tacrolimus therapy association

Number of patients

232

163

Age at the time of transplantation (year)a

53.1 (19.5; 68.7)

52.6 (19; 68.7)

Gender (male/female)

175/57

128/35

Bodyweight at the time of transplantation (kg)a

78 (47; 120)

80 (47; 120)

Primary disease

Non-ischaemic DCM

101

68

Ischaemic CM

78

57

Congenital heart disease

17

11

Hypertrophic CM

9

8

Restrictive CM

8

5

ARVD

3

2

Idiopathic DCM

3

2

Other

13

10

  1. ARVD, arrhythmogenic right ventricular dysplasia; CM, cardiomyopathy; DCM, dilated CM.
  2. aMedian (min; max).